Concepedia

Author

Nami Masubuchi

Juntendo UniversityORCID

Also Known As

N. Masubuchi, Nami Masubuchi

18

Publications

594

Citations

9

H-Index

20

Concepts

All Affiliations

Juntendo UniversityKitasato UniversityNational Center of Neurology and Psychiatry
NM

About

Nami Masubuchi is an author at Juntendo University specializing in medicine, cell biology, and cellular physiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

187

2

Cell Biology

3

3

122

3

Biochemistry

2

2

123

4

Health Sciences

1

1

40

5

Natural Sciences

1

1

65

Nami Masubuchi

×

9

Publications

588

Citations

9

H-Index

YearCitations

Activation of the thrombopoietin receptor by mutant calreticulin in CALR-mutant myeloproliferative neoplasms

Marito Araki, Yinjie Yang, Nami Masubuchi,

Blood

2016

273

Autologous Transplantation of SM/C-2.6+ Satellite Cells Transduced with Micro-dystrophin CS1 cDNA by Lentiviral Vector into mdx Mice

Madoka Ikemoto‐Uezumi, So‐ichiro Fukada, Akiyoshi Uezumi,

Molecular Therapy

2007

85

Homomultimerization of mutant calreticulin is a prerequisite for MPL binding and activation

Marito Araki, Yinjie Yang, Misa Imai,

Leukemia

2018

65

Mutant calreticulin interacts with MPL in the secretion pathway for activation on the cell surface

Nami Masubuchi, Marito Araki, Yinjie Yang,

Leukemia

2019

58

Reduced proliferative activity of primary POMGnT1-null myoblasts in vitro

Yuko Miyagoe‐Suzuki, Nami Masubuchi, Kaori Miyamoto,

Mechanisms of Development

2008

40

Subcellular Localization of Dystrophin Isoforms in Cardiomyocytes and Phenotypic Analysis of Dystrophin-deficient Mice Reveal Cardiac Myopathy is Predominantly Caused by a Deficiency in Full-length Dystrophin

Nami Masubuchi, Yuichi Shidoh, Shunzo Kondo,

EXPERIMENTAL ANIMALS

2013

24

Skewed megakaryopoiesis in human induced pluripotent stem cell‐derived haematopoietic progenitor cells harbouring calreticulin mutations

Hiraku Takei, Yoko Edahiro, Shuichi Mano,

British Journal of Haematology

2018

21

Phase 1 Clinical Trial of PPMX‐T003, a Novel Human Monoclonal Antibody Specific for Transferrin Receptor 1, to Evaluate Its Safety, Pharmacokinetics, and Pharmacodynamics

Yoichiro Ogama, Yuji Kumagai, Norio Komatsu,

Clinical Pharmacology in Drug Development

2022

12

Therapeutic Potential of an Antibody Targeting the Cleaved Form of Mutant Calreticulin in Myeloproliferative Neoplasms

Yoshihiko Kihara, Marito Araki, Misa Imai,

Blood

2020

10

Page 1